Naltrexone dosage

V. Navaratnam, A. Jamaludin, N. Raman, M. Mohamed, and S.M. Mansor, Determination of naltrexone dosage for narcotic agonist in detoxified Asian addicts. Drug Alcohol Dependence, 34,231-236,1994. 

The best conclusion that can be drawn from these data is perhaps that treatment with naltrexone may offer promise for some, but certainly not all, patients with self-injury. Treatment effects may depend on background opioid levels, dosage, and treatment regimen. Noninvasive measures that predict individual treatment response have not been established. Self-injury is a heterogeneous phenomenon from a clinical and biological perspective (Buitelaar, 1993 Willemsen-Swinkels et ah, 1998). Further studies are required in this area, and and should include carefully clinically documented cases, large samples, and controlled designs. At this time, the use of naltrexone for the treatment of self-injury is to be considered experimental. 

Willemsen-Swinkels, S.H.N., Buitelaar, J.K., Weijnen, F.G., and Van Engeland, H. (1995c) Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatr Res 58 203—215. 

---